SynthesisAnnals of hematology2024

Efficacy and safety of fostamatinib in refractory immune thrombocytopenia: a meta-analysis from randomized controlled trials.

Songphol Tungjitviboonkun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.